Page last updated: 2024-08-26

3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine and Liver Diseases

3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine has been researched along with Liver Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brouwer, KL; Cheeseman, SH; Eyster, E; Lemon, SM; Moore, KH; Opheim, K; Raasch, RH; van der Horst, CM1

Trials

1 trial(s) available for 3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine and Liver Diseases

ArticleYear
Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:12

    Topics: Administration, Oral; Adult; Antiviral Agents; Biological Availability; Female; HIV Infections; Humans; Injections, Intravenous; Liver Diseases; Male; Middle Aged; Zidovudine

1995